ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TTNP Titan Pharmaceuticals Inc

3.40
0.16 (4.94%)
Last Updated: 16:28:42
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 121k98k83k3k0000
Operating Income -2.61M-1.7M-1.59M-2.06M-1.93M-1.06M-2.07M-754k
Pre Tax Income -2.57M-1.68M-1.59M-338k-1.97M-1.06M-2.09M-763k
Net Income -2.57M-1.68M-1.59M-338k-1.97M-1.06M-2.09M-763k
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -2.59M-1.7M-1.59M-327k-1.96M-1.06M-2.09M-763k
EBITDA -2.57M-1.65M-1.55M-2.03M-1.93M-1.06M-2.07M-754k
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 15.07M215k6.62M3.61M4.84M1.53M557k184k
Operating Income 4.34M-14.5M-8.26M-16.84M-7.35M-9.35M-10.24M-7.28M
Pre Tax Income 5.14M-14.31M-9.02M-16.46M-7.41M-8.78M-10.21M-5.57M
Net Income 5.14M-14.31M-9.31M-16.46M-18.24M-8.78M-10.21M-5.57M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.235-0.656-0.684-0.284-2.355-0.834-0.653-0.336
EBIT 4.27M-14.56M-8.27M-16.6M-5.72M-8.78M-10.26M-5.57M
EBITDA 4.72M-14.09M-7.88M-16.6M-7.06M-9.13M-10.04M-7.17M